Business · 09/06/2023
FDA Announces Final Guidance for Evaluating Drug Interactions with Combined Oral Contraceptives
The FDA has released a final guidance to help pharmaceutical companies assess and mitigate potential risks associated with combined oral contraceptives, a crucial step in ensuring the safety of these medications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →